Advertisement
Screener

Indivior Pharmaceuticals, Inc. (INDV) Auditor

Indivior Pharmaceuticals, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Richmond, Virginia.
  • 2025-03-03: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Richmond, Virginia.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31PricewaterhouseCoopers LLP238Richmond, VirginiaYes
2025-03-032024-12-31PricewaterhouseCoopers LLP238Richmond, VirginiaYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Edgewise Therapeutics, Inc. (EWTX)United States$4.470B-22.23
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Veradermics, Inc (MANE)United States$4.839B
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Erasca, Inc. (ERAS)United States$5.073B-19.96